Literature DB >> 20966109

Critical interactions between Global Fund-supported programmes and health systems: a case study in Indonesia.

Monica Desai1, James W Rudge, Wiku Adisasmito, Sandra Mounier-Jack, Richard Coker.   

Abstract

The Global Fund to Fight AIDS, Tuberculosis and Malaria has played an important role in financing the response to HIV/AIDS and tuberculosis (TB) in Indonesia. As part of a series of case studies, we assessed the nature and extent of integration of Global Fund portfolios into the national HIV and TB programmes, integration of the HIV and TB programmes within the general health system, and system-wide effects of Global Fund support on the health care system in Indonesia. The study relied on a literature review and interviews with 22 key informants using the Systemic Rapid Assessment Toolkit and thematic analysis. Global Fund programmes in Indonesia are highly vertical and centralized, in contrast with the decentralized nature of the Indonesian health system. Consequently, there is more integration of all functions at local levels than centrally. There is a high level of integration of planning of Global Fund HIV and TB portfolios into the National AIDS and TB programmes and some limited integration of these programmes with other disease programmes, through joint working groups. Other synergies include strengthening of stewardship and governance and increased staff recruitment encouraged by incentive payments and training. Monitoring and evaluation functions of the Global Fund programmes are not integrated with the disease programmes, with parallel indicators and reporting systems. System-wide effects include greater awareness of governance and stewardship in response to the temporary suspension of Global Fund funding in 2008, and increased awareness of the need to integrate programme planning, financing and service delivery. Global Fund investment has freed up resources for other programmes, particularly at local levels. However, this may hinder a robust exit strategy from Global Fund funding. Furthermore, Global Fund monetary incentives may result in staff shifting into HIV and TB programmes.

Entities:  

Mesh:

Year:  2010        PMID: 20966109     DOI: 10.1093/heapol/czq057

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  6 in total

1.  Negative health system effects of Global Fund's investments in AIDS, tuberculosis and malaria from 2002 to 2009: systematic review.

Authors:  Josip Car; Tapio Paljärvi; Mate Car; Ayodele Kazeem; Azeem Majeed; Rifat Atun
Journal:  JRSM Short Rep       Date:  2012-10-15

2.  District Health Officer Perceptions of PEPFAR's Influence on the Health System in Uganda, 2005-2011.

Authors:  Nathaniel Lohman; Amy Hagopian; Samuel Abimerech Luboga; Bert Stover; Travis Lim; Frederick Makumbi; Noah Kiwanuka; Flavia Lubega; Assay Ndizihiwe; Eddie Mukooyo; Scott Barnhart; James Pfeiffer
Journal:  Int J Health Policy Manag       Date:  2017-02-01

3.  "If donors woke up tomorrow and said we can't fund you, what would we do?" A health system dynamics analysis of implementation of PMTCT option B+ in Uganda.

Authors:  Tanya Doherty; Donnela Besada; Ameena Goga; Emmanuelle Daviaud; Sarah Rohde; Nika Raphaely
Journal:  Global Health       Date:  2017-07-26       Impact factor: 4.185

4.  Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund.

Authors:  Yot Teerawattananon; Kate McQueston; Amanda Glassman; Jomkwan Yothasamut; Chaw Yin Myint
Journal:  Global Health       Date:  2013-08-21       Impact factor: 4.185

Review 5.  Systematic review on human resources for health interventions to improve maternal health outcomes: evidence from low- and middle-income countries.

Authors:  Zohra S Lassi; Nabiha B Musavi; Blerta Maliqi; Nadia Mansoor; Andres de Francisco; Kadidiatou Toure; Zulfiqar A Bhutta
Journal:  Hum Resour Health       Date:  2016-03-12

6.  Daily struggle to take antiretrovirals: a qualitative study in Papuans living with HIV and their healthcare providers.

Authors:  Elfride Irawati Sianturi; Elmiawati Latifah; Ari Probandari; Christantie Effendy; Katja Taxis
Journal:  BMJ Open       Date:  2020-09-28       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.